TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

29 hedge funds and large institutions have $37.9M invested in Theriva Biologics in 2014 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
29
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$5.84M
2
+$2.99M
3
+$1.33M
4
TC
TFS Capital
Pennsylvania
+$230K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$115K

Top Sellers

1
-$491K
2
-$265K
3
-$189K
4
Goldman Sachs
Goldman Sachs
New York
-$76K
5
BCM
Bridgeway Capital Management
Texas
-$71K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$16K
27
$15K
28
$14K
29
$9K
30
$4K
31
$3K
32
$1K
33
$1K
34
$6
35
–
36
–
37
–
38
–
39
–
40
–
1
2